Literature DB >> 20562531

A comparison of human and macaque (Macaca mulatta) immunoglobulin germline V regions and its implications for antibody engineering.

Philippe Thullier1, Siham Chahboun, Thibaut Pelat.   

Abstract

Seventy-five V regions encoded by the sequenced genome of one Macaca mulatta specimen have been identified by homology, and paired with similar human counterparts. When the human V region of each pair presented no allelic polymorphism, it was directly compared with its homolog. This was the case for 37 pairs, and percents of identity ranged between 84 to 97%. When the human V region presented allelic polymorphism, this polymorphism was found to be significantly smaller (p<0.0001, p<0.0001, p = 0.03 for IGHV, IGLV, IGKV regions respectively), 4.2-fold on average, than the differences observed between human and macaque V regions. Similar results were obtained when analysing framework regions (FRs) only. These results, in agreement with others, demonstrate the existence of differences between human and macaque V regions, confirm the need for the humanization of macaque V regions intended for therapeutic use and call into question the validity of patents relying on the "undistinguishable" character of human and macaque V regions or FRs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20562531      PMCID: PMC2958574          DOI: 10.4161/mabs.2.5.12545

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  20 in total

Review 1.  IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains.

Authors:  Marie-Paule Lefranc; Christelle Pommié; Manuel Ruiz; Véronique Giudicelli; Elodie Foulquier; Lisa Truong; Valérie Thouvenin-Contet; Gérard Lefranc
Journal:  Dev Comp Immunol       Date:  2003-01       Impact factor: 3.636

Review 2.  Idiotypic networks: toward a renaissance?

Authors:  Ulrich Behn
Journal:  Immunol Rev       Date:  2007-04       Impact factor: 12.988

3.  Analyzing the "degree of humanness" of antibody sequences.

Authors:  K R Abhinandan; Andrew C R Martin
Journal:  J Mol Biol       Date:  2007-03-14       Impact factor: 5.469

4.  Local alignment statistics.

Authors:  S F Altschul; W Gish
Journal:  Methods Enzymol       Date:  1996       Impact factor: 1.600

5.  Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694.

Authors:  Emmanuelle Laffly; Ludivine Danjou; Florence Condemine; Dominique Vidal; Emmanuel Drouet; Marie-Paule Lefranc; Chantal Bottex; Philippe Thullier
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

6.  Evolutionary and biomedical insights from the rhesus macaque genome.

Authors:  Richard A Gibbs; Jeffrey Rogers; Michael G Katze; Roger Bumgarner; George M Weinstock; Elaine R Mardis; Karin A Remington; Robert L Strausberg; J Craig Venter; Richard K Wilson; Mark A Batzer; Carlos D Bustamante; Evan E Eichler; Matthew W Hahn; Ross C Hardison; Kateryna D Makova; Webb Miller; Aleksandar Milosavljevic; Robert E Palermo; Adam Siepel; James M Sikela; Tony Attaway; Stephanie Bell; Kelly E Bernard; Christian J Buhay; Mimi N Chandrabose; Marvin Dao; Clay Davis; Kimberly D Delehaunty; Yan Ding; Huyen H Dinh; Shannon Dugan-Rocha; Lucinda A Fulton; Ramatu Ayiesha Gabisi; Toni T Garner; Jennifer Godfrey; Alicia C Hawes; Judith Hernandez; Sandra Hines; Michael Holder; Jennifer Hume; Shalini N Jhangiani; Vandita Joshi; Ziad Mohid Khan; Ewen F Kirkness; Andrew Cree; R Gerald Fowler; Sandra Lee; Lora R Lewis; Zhangwan Li; Yih-Shin Liu; Stephanie M Moore; Donna Muzny; Lynne V Nazareth; Dinh Ngoc Ngo; Geoffrey O Okwuonu; Grace Pai; David Parker; Heidie A Paul; Cynthia Pfannkoch; Craig S Pohl; Yu-Hui Rogers; San Juana Ruiz; Aniko Sabo; Jireh Santibanez; Brian W Schneider; Scott M Smith; Erica Sodergren; Amanda F Svatek; Teresa R Utterback; Selina Vattathil; Wesley Warren; Courtney Sherell White; Asif T Chinwalla; Yucheng Feng; Aaron L Halpern; Ladeana W Hillier; Xiaoqiu Huang; Pat Minx; Joanne O Nelson; Kymberlie H Pepin; Xiang Qin; Granger G Sutton; Eli Venter; Brian P Walenz; John W Wallis; Kim C Worley; Shiaw-Pyng Yang; Steven M Jones; Marco A Marra; Mariano Rocchi; Jacqueline E Schein; Robert Baertsch; Laura Clarke; Miklós Csürös; Jarret Glasscock; R Alan Harris; Paul Havlak; Andrew R Jackson; Huaiyang Jiang; Yue Liu; David N Messina; Yufeng Shen; Henry Xing-Zhi Song; Todd Wylie; Lan Zhang; Ewan Birney; Kyudong Han; Miriam K Konkel; Jungnam Lee; Arian F A Smit; Brygg Ullmer; Hui Wang; Jinchuan Xing; Richard Burhans; Ze Cheng; John E Karro; Jian Ma; Brian Raney; Xinwei She; Michael J Cox; Jeffery P Demuth; Laura J Dumas; Sang-Gook Han; Janet Hopkins; Anis Karimpour-Fard; Young H Kim; Jonathan R Pollack; Tomas Vinar; Charles Addo-Quaye; Jeremiah Degenhardt; Alexandra Denby; Melissa J Hubisz; Amit Indap; Carolin Kosiol; Bruce T Lahn; Heather A Lawson; Alison Marklein; Rasmus Nielsen; Eric J Vallender; Andrew G Clark; Betsy Ferguson; Ryan D Hernandez; Kashif Hirani; Hildegard Kehrer-Sawatzki; Jessica Kolb; Shobha Patil; Ling-Ling Pu; Yanru Ren; David Glenn Smith; David A Wheeler; Ian Schenck; Edward V Ball; Rui Chen; David N Cooper; Belinda Giardine; Fan Hsu; W James Kent; Arthur Lesk; David L Nelson; William E O'brien; Kay Prüfer; Peter D Stenson; James C Wallace; Hui Ke; Xiao-Ming Liu; Peng Wang; Andy Peng Xiang; Fan Yang; Galt P Barber; David Haussler; Donna Karolchik; Andy D Kern; Robert M Kuhn; Kayla E Smith; Ann S Zwieg
Journal:  Science       Date:  2007-04-13       Impact factor: 47.728

7.  Isolation of a human-like antibody fragment (scFv) that neutralizes ricin biological activity.

Authors:  Thibaut Pelat; Michael Hust; Martha Hale; Marie-Paule Lefranc; Stefan Dübel; Philippe Thullier
Journal:  BMC Biotechnol       Date:  2009-06-30       Impact factor: 2.563

8.  High-affinity, human antibody-like antibody fragment (single-chain variable fragment) neutralizing the lethal factor (LF) of Bacillus anthracis by inhibiting protective antigen-LF complex formation.

Authors:  Thibaut Pelat; Michael Hust; Emmanuelle Laffly; Florence Condemine; Chantal Bottex; Dominique Vidal; Marie-Paule Lefranc; Stefan Dübel; Philippe Thullier
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

9.  Germline humanization of a non-human primate antibody that neutralizes the anthrax toxin, by in vitro and in silico engineering.

Authors:  Thibaut Pelat; Hugues Bedouelle; Anthony R Rees; Susan J Crennell; Marie-Paule Lefranc; Philippe Thullier
Journal:  J Mol Biol       Date:  2008-10-19       Impact factor: 5.469

10.  Identification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatus.

Authors:  Mark Schütte; Philippe Thullier; Thibaut Pelat; Xenia Wezler; Philip Rosenstock; Dominik Hinz; Martina Inga Kirsch; Mike Hasenberg; Ronald Frank; Thomas Schirrmann; Matthias Gunzer; Michael Hust; Stefan Dübel
Journal:  PLoS One       Date:  2009-08-13       Impact factor: 3.240

View more
  16 in total

Review 1.  Molecular engineering of antibodies for therapeutic and diagnostic purposes.

Authors:  Frédéric Ducancel; Bruno H Muller
Journal:  MAbs       Date:  2012-07-01       Impact factor: 5.857

2.  Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120.

Authors:  Anthony P West; Ron Diskin; Michel C Nussenzweig; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-27       Impact factor: 11.205

3.  Cynomolgus macaque (Macaca fascicularis) immunoglobulin heavy chain locus description.

Authors:  Guo-Yun Yu; Suzanne Mate; Karla Garcia; Michael D Ward; Ernst Brueggemann; Matthew Hall; Tara Kenny; Mariano Sanchez-Lockhart; Marie-Paule Lefranc; Gustavo Palacios
Journal:  Immunogenetics       Date:  2016-05-27       Impact factor: 2.846

4.  Neutralizing capacity of monoclonal antibodies that recognize peptide sequences underlying the carbohydrates on gp41 of simian immunodeficiency virus.

Authors:  José M Martinez-Navio; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-09-19       Impact factor: 5.103

5.  Camelid Ig V genes reveal significant human homology not seen in therapeutic target genes, providing for a powerful therapeutic antibody platform.

Authors:  Alex Klarenbeek; Khalil El Mazouari; Aline Desmyter; Christophe Blanchetot; Anna Hultberg; Natalie de Jonge; Rob C Roovers; Christian Cambillau; Sylvia Spinelli; Jurgen Del-Favero; Theo Verrips; Hans J de Haard; Ikbel Achour
Journal:  MAbs       Date:  2015       Impact factor: 5.857

6.  Immunogenicity of mAbs in non-human primates during nonclinical safety assessment.

Authors:  Peter J K van Meer; Marlous Kooijman; Vera Brinks; Christine C Gispen-de Wied; Beatriz Silva-Lima; Ellen H M Moors; Huub Schellekens
Journal:  MAbs       Date:  2013-06-06       Impact factor: 5.857

7.  Isolation of a nanomolar scFv inhibiting the endopeptidase activity of botulinum toxin A, by single-round panning of an immune phage-displayed library of macaque origin.

Authors:  Siham Chahboun; Michael Hust; Yvonne Liu; Thibaut Pelat; Sebastian Miethe; Saskia Helmsing; Russell Ga Jones; Dorothea Sesardic; Philippe Thullier
Journal:  BMC Biotechnol       Date:  2011-11-23       Impact factor: 2.563

8.  HIV-1 Vaccine-elicited Antibodies Reverted to Their Inferred Naive Germline Reveal Associations between Binding Affinity and in vivo Activation.

Authors:  Kaifan Dai; Salar N Khan; Yimeng Wang; Linling He; Javier Guenaga; Jidnyasa Ingale; Christopher Sundling; Sijy O'Dell; Krisha McKee; Ganesh Phad; Martin Corcoran; Richard Wilson; John R Mascola; Jiang Zhu; Yuxing Li; Gunilla B Karlsson Hedestam; Richard T Wyatt
Journal:  Sci Rep       Date:  2016-02-16       Impact factor: 4.379

9.  Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.

Authors:  Sebastian Miethe; Christine Rasetti-Escargueil; Arnaud Avril; Yvonne Liu; Siham Chahboun; Hannu Korkeala; Christelle Mazuet; Michel-Robert Popoff; Thibaut Pelat; Philippe Thullier; Dorothea Sesardic; Michael Hust
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

10.  Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.

Authors:  Sebastian Miethe; Christine Rasetti-Escargueil; Yvonne Liu; Siham Chahboun; Thibaut Pelat; Arnaud Avril; André Frenzel; Thomas Schirrmann; Philippe Thullier; Dorothea Sesardic; Michael Hust
Journal:  MAbs       Date:  2014-01-09       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.